Johnson & Johnson is Down for the 2nd Day in a Row

The Daily View for Johnson & Johnson

  • Currently, JNJ’s price is down $-0.55 (-0.35%) from the day prior.
  • It’s been a feast for bears operating on the daily timeframe, as Johnson & Johnson has now gone down 4 of the past 5 days.
  • If you’re a trader with a preference for rangebound markets, you may wish to note that there isn’t a clear trend on the 20, 50 and 100 day timeframes.
  • Most noteworthy in the world of moving averages on the daily chart is that the 20 day moving average has been crossed, so that price is now turning above it. The moving averages on the daily timeframe suggest a bearishness in price, as the 20, 50, 100 and 200 are all in a bearish alignment — meaning the shorter duration moving averages are below the longer duration averages, implying a stable downward trend.

Johnson & Johnson’s hourly price chart is shown below.

JNJ

The Daily View for Johnson & Johnson

  • Currently, JNJ’s price is down $-0.67 (-0.42%) from the day prior.
  • It’s been a feast for bears operating on the daily timeframe, as Johnson & Johnson has now gone down 4 of the past 5 days.
  • If you’re a trend trader, consider that the strongest clear trend on the daily chart exists on the 50 day timeframe.
  • The moving averages on the daily timeframe suggest a bullishness in price, as the 20, 50, 100 and 200 are all in a bullish alignment — meaning the shorter durations are above the longer duration averages, implying a sound upward trend.

Below is a daily price chart of Johnson & Johnson.

JNJ

Featured Johnson & Johnson Idea From TradingView

Below is a trading comment entitled JNJ 66% efficacy Covid vaccine paused for rare blood clots you may find interesting:

U.S. regulators have temporarily halted use of Johnson & Johnson’s COVID-19 vaccine while they examine six cases of rare blood clots that have been reported in people who have received the shot.AstraZeneca’s AZN, COVID-19 vaccine, which has not been authorized in the U.S., has faced similar concerns of rare blood clots, with some European countries halting use of the vaccine.The AstraZeneca and the J&J vaccines are both adenovirus vaccines, which differ from the mRNA vaccines developed by BioNTech SE BNTX /Pfizer Inc. PFE, and Moderna Inc. MRNA. (marketwatch.com)Johnson & Johnso…

CryptoFundManager